These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 143980)

  • 1. Structure of fibrinogen and degradation products of fibrinogen and fibrin.
    Gaffney PJ
    Br Med Bull; 1977 Sep; 33(3):245-51. PubMed ID: 143980
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.
    Gaffney PJ
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():10-7. PubMed ID: 6448869
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 7. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential degradation by plasmin of fragment E derived from fibrin and fibrinogen.
    Wallin R; Belew M; Gerdin B; Saldeen T
    Thromb Res; 1980 Aug; 19(3):441-5. PubMed ID: 6449096
    [No Abstract]   [Full Text] [Related]  

  • 10. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1983 Jul; 32(7):680-4. PubMed ID: 6222931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
    Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
    Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary structure of fibrinogen, its relation to conformation and function of the molecule].
    Lugovskoĭ EV
    Ukr Biokhim Zh (1978); 1982; 54(5):578-94. PubMed ID: 6215752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory pathway for fibrinogen biosynthesis involving an indirect feedback loop.
    Fuller GM; Ritchie DG
    Ann N Y Acad Sci; 1982; 389():308-22. PubMed ID: 6212017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: The degradation of soluble versus insoluble fibrin in vivo.
    Lipinski B; Gurewich V
    Thromb Res; 1976 Jan; 8(1):119-20. PubMed ID: 129882
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 20. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.